Evidence map›Paper›PMID 27561354›Full record

ArticleNature communications2016

Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to fine-tune DNA-end resection.

Lorenza P Ferretti, Sarah-Felicitas Himmels, Anika Trenner, Christina Walker, Christine von Aesch, Aline Eggenschwiler, Olga Murina, Radoslav I Enchev, Matthias Peter, Raimundo Freire and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Degrons: defining the rules of protein degradation.Nature reviews. Molecular cell biology · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Kelch-like proteins in the gastrointestinal tumors.Acta pharmacologica Sinica · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. The roles of KLHL family members in human cancers.American journal of cancer research · 2022
    Review
  20. PLK1-mediated phosphorylation of PPIL2 regulates HRFrontiers in cell and developmental biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Lorenza P FerrettiUniversity of Zurich, Institute of Molecular Cancer Research, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Sarah-Felicitas HimmelsUniversity of Zurich, Institute of Molecular Cancer Research, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Anika TrennerUniversity of Zurich, Institute of Molecular Cancer Research, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Christina WalkerUniversity of Zurich, Institute of Molecular Cancer Research, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Christine von AeschUniversity of Zurich, Institute of Molecular Cancer Research, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Aline EggenschwilerUniversity of Zurich, Institute of Molecular Cancer Research, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Olga MurinaUniversity of Zurich, Institute of Molecular Cancer Research, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Radoslav I EnchevETH Zurich, Institute of Biochemistry, Department of Biology, Otto-Stern-Weg 3, 8093 Zurich, Switzerland.
Matthias PeterETH Zurich, Institute of Biochemistry, Department of Biology, Otto-Stern-Weg 3, 8093 Zurich, Switzerland.
Raimundo FreireUnidad de Investigación, Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas, Ofra s/n, La Cuesta, La Laguna, Tenerife, Spain.
Antonio PorroUniversity of Zurich, Institute of Molecular Cancer Research, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Alessandro A SartoriUniversity of Zurich, Institute of Molecular Cancer Research, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
University of Zurich · CHETH Zurich · CHHospital Universitario de Canarias · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human CtIP is a decisive factor in DNA double-strand break repair pathway choice by enabling DNA-end resection, the first step that differentiates homologous recombination (HR) from non-homologous end-joining (NHEJ). To coordinate appropriate and timely execution of DNA-end resection, CtIP function is tightly controlled by multiple protein-protein interactions and post-translational modifications. Here, we identify the Cullin3 E3 ligase substrate adaptor Kelch-like protein 15 (KLHL15) as a new interaction partner of CtIP and show that KLHL15 promotes CtIP protein turnover via the ubiquitin-proteasome pathway. A tripeptide motif (FRY) conserved across vertebrate CtIP proteins is essential for KLHL15-binding; its mutation blocks KLHL15-dependent CtIP ubiquitination and degradation. Consequently, DNA-end resection is strongly attenuated in cells overexpressing KLHL15 but amplified in cells either expressing a CtIP-FRY mutant or lacking KLHL15, thus impacting the balance between HR and NHEJ. Collectively, our findings underline the key importance and high complexity of CtIP modulation for genome integrity.

Indexed as

DNA End-Joining RepairCarrier ProteinsCell LineCullin ProteinsDNA Breaks, Double-StrandedEndodeoxyribonucleasesHomologous RecombinationHumansMicrofilament ProteinsMutationNuclear ProteinsProtein Interaction Domains and MotifsProteolysisUbiquitinationCarrier ProteinsCUL3 protein, humanCullin ProteinsEndodeoxyribonucleasesKLHL15 protein, humanMicrofilament ProteinsNuclear ProteinsRBBP8 protein, human

Identifiers

PMID27561354
PMCPMC5007465
OpenAlexW2515412931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.